ISSN 0017-8748 (Print); ISSN 1365-2524 (Online)
Publisher: Wiley-Blackwell
In This Issue pp. 1401-1401(1)
Expanding Access to Triptans: Assessment of Clinical Outcome pp. 1402-1413(12) Authors: Cady, Roger K.; Goldstein, Jerome; Silberstein, Stephen; Juhász, Márta; Ramsey, Karen; Rodgers, Anthony; Hustad, Carolyn M.; Ho, Tony
The Safety of Sumatriptan and Naratriptan in Pregnancy: What Have We Learned? pp. 1414-1422(9) Authors: Cunnington, Marianne; Ephross, Sara; Churchill, Paige
Reduced Adverse Event Profile of Orally Inhaled DHE (MAP0004) vs IV DHE: Potential Mechanism pp. 1423-1434(12) Authors: Cook, Robert O.; Shrewsbury, Stephen B.; Ramadan, Nabih M.
Needle-Free Subcutaneous Sumatriptan (Sumavel™ DosePro™): Bioequivalence and Ease of Use pp. 1435-1444(10) Authors: Brandes, Jan Lewis; Cady, Roger K.; Freitag, Fred G.; Smith, Timothy R.; Chandler, Patricia; Fox, Anthony W.; Linn, Lawrence; Farr, Stephen J.
Rapid Oral Transmucosal Absorption of Sumatriptan, and Pharmacodynamics in Acute Migraine pp. 1445-1453(9) Authors: Dilone, Enrique; Bergstrom, David; Cabana, Bernard; Nedumpara, Mercy; Fox, Anthony W.
Topiramate for Migraine Prevention in a Naturalistic Setting: Results From an Open Label, Flexible Dose Study pp. 1454-1465(12) Authors: Nelles, Gereon; Delbrück, Anette; Schulze, Lutz; Kademann, Barbara; Bornhoevd, Karin; Schäfer, Susanne; Schäuble, Barbara
A Double-Blind Comparison of OnabotulinumtoxinA (BOTOX®) and Topiramate (TOPAMAX®) for the Prophylactic Treatment of Chronic Migraine: A Pilot Study pp. 1466-1478(13) Authors: Mathew, Ninan T.; Jaffri, Sayyed Farhan A.
Occipital Nerve Blocks: Effect of Symptomatic Medication: Overuse and Headache Type on Failure Rate pp. 1479-1485(7) Authors: Tobin, Joshua A.; Flitman, Stephen S.
Serotonin Effects on Sleep and Emotional Disorders in Adolescent Migraine pp. 1486-1492(7) Authors: Pakalnis, Ann; Splaingard, Mark; Splaingard, Deborah; Kring, Donna; Colvin, Andrew
A Twin Study of Depression and Migraine: Evidence for a Shared Genetic Vulnerability pp. 1493-1502(10) Authors: Schur, Ellen A.; Noonan, Carolyn; Buchwald, Dedra; Goldberg, Jack; Afari, Niloofar
Prevalence and Incidence of Headache in Adolescent Finnish Twins pp. 1503-1512(10) Authors: Virtanen, Ruut; Aromaa, Minna; Koskenvuo, Markku; Sillanpää, Matti; Rose, Richard J.; Metsähonkala, Liisa; Helenius, Hans; Anttila, Pirjo; Kaprio, Jaakko
Frequency of Chronic Headaches in Japanese Patients With Multiple Sclerosis: With Special Reference to Opticospinal and Common Forms of Multiple Sclerosis pp. 1513-1520(8) Authors: Doi, Hikaru; Matsushita, Takuya; Isobe, Noriko; Ishizu, Takaaki; Ohyagi, Yasumasa; Kira, Jun-ichi
Occipital Nerve Blocks: When and What to Inject? pp. 1521-1533(13) Authors: Tobin, Joshua; Flitman, Stephen
Images From Headache: Intracranial Hypotension Complicating Marfan's Syndrome pp. 1534-1535(2) Authors: Decontee, Jimmeh; Joel, Cure; John, Rothrock
Expert Opinion: What Causes Migraine: Which Physician Explanation Do Patients Prefer and Understand? pp. 1536-1540(5) Authors: Evans, Randolph W.; Evans, Rochelle E.
Middle Meningeal Artery Dilatation in Migraine pp. 1541-1543(3) Author: Shevel, Elliot
Higher Serum Levels of s100b and Lower Serum Levels of NSE in Migraineurs pp. 1544-1544(1)
Higher Serum Levels of s100b and Lower Serum Levels of NSE in Migraineurs: A Response pp. 1544-1545(2)
Generic Topiramate for Migraine Prevention: Is Bioequivalence the Same as Therapeutic Equivalence? pp. 1545-1546(2)
Association of Hemicrania Continua and Temporomandibular Dysfunction: The Role of Each Team Player pp. 1547-1548(2)
A Comment on Remarks Regarding Schoonman et al Migraine Headache Is Not Associated With Cerebral or Meningeal Vasodilatation – A 3T Magnetic Resonance Angiography Study pp. 1548-1549(2)
Retropharyngeal Tendonitis pp. 1549-1550(2)
Resident and Fellow Section pp. 1551-1554(4) Author: Levin, Morris
Headache Reviewers pp. 1555-1558(4)
Botox Haiku / The Challenging Patient pp. 1559-1559(1)